Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL

Despite improved survival in the Rituximab (R) era, a considerable number of patients with diffuse large B-cell lymphoma (DLBCL) ultimately die from the disease. Functional imaging using [(18)F]fluorodeoxyglucose-PET is suggested for assessment of residual viable tumor very early during treatment bu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Herrmann, Ken, Buck, Andreas K., Schuster, Tibor, Abbrederis, Kathrin, Blümel, Christina, Santi, Ivan, Rudelius, Martina, Wester, Hans-Jürgen, Peschel, Christian, Schwaiger, Markus, Dechow, Tobias, Keller, Ulrich
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4147305/
https://ncbi.nlm.nih.gov/pubmed/24979177
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados